Application of high resolution melting (HRM) analysis in detection of PDGFRA gene mutations among chronic myeloid leukemia patients treated with imanitib mesylate
A molecular detection of PDGFRA variants is highly relevant for prognosis and therapy prediction in chronic myeloid leukemia (CML) patients treated with Imatinib mesylate (IM). Even though IM has shown an excellent efficacy as a frontline treatment in CML, emerging of resistance towards IM in som...
Saved in:
Main Author: | Rashid, Nur Sabrina Abd |
---|---|
Format: | Thesis |
Language: | English |
Published: |
2020
|
Subjects: | |
Online Access: | http://eprints.usm.my/49465/1/Nur%20Sabrina%20Abd%20Rashid-24%20pages.pdf http://eprints.usm.my/49465/ |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Detection of PDGFRA mutations at exons 12 and 18 among chronic myeloid leukemia patients treated with imatinib mesylate
by: Razali, Ruzi Hamimi
Published: (2015) -
Imatinib mesylate in the treatment of chronic myeloid leukemia: a local experience
by: Bee, P.C., et al.
Published: (2006) -
Contribution of BCR-ABL kinase domain mutations to imatinib mesylate resistance in Philadelphia chromosome positive Malaysian chronic myeloid leukemia patients
by: Elias, Marjanu Hikmah, et al.
Published: (2012) -
Identification of copy number alterations by array comparative genomic hybridization in patients with late chronic or accelerated phase chronic myeloid leukemia treated with imatinib mesylate
by: Nadarajan, V.S., et al.
Published: (2011) -
Imatinab mesylate treatment in Chronic Myeloid
Leukemia (CML)- understanding the
fundamental pharmacokinetic and
pharmacogenetic mechanisms for variation in
response
by: Ankathil, Ravindran
Published: (2016)